A systematic review on the impact of pharmacist‐provided services on patients’ health outcomes in Arab countries

El-Awaisi, Alla; Al-Shaibi, Samaher; Al-Ansari, Radoa; Naseralallah, Lina; Awaisu, Ahmed

doi:10.1111/jcpt.13633

Cited by 11 publications

(10 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings underscore the gravity of the rising burden of polypharmacy among patients with CKD and highlight the pressing need to adopt some of the interventions that have been proposed to reduce the burden of polypharmacy in the general population. This includes comprehensive medication reviews, deprescribing algorithms, potentially inappropriate medications (PIM) screening tools (e.g., Beers criteria), and clinical pharmacist-led interventions (Cooper et al, 2015;El-Awaisi et al, 2022;Isleem et al, 2022). It is noteworthy that these interventions are not widespread and that the research on the effectiveness of such strategies on clinically important outcomes is limited (Cooper et al, 2015).…”

Section: Discussionmentioning

confidence: 99%

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background and objectives: Polypharmacy and chronic kidney disease (CKD) are becoming increasingly common due to an ageing population and the rise of multimorbidity. In line with the therapeutic guidelines, managing CKD and its complications necessitates prescribing multiple medications, which predisposes patients to polypharmacy. The aim of this systematic review and meta-analysis is to describe the prevalence of polypharmacy in patients with CKD and to explore the global trends of factors driving any apparent variability in prevalence estimates.Methods: PubMed, Scopus, the Cochrane Database of Systematic Reviews (CDSR), and Google Scholar were searched from 1999 to November 2021. Study selection, data extraction, and critical appraisal were conducted by two independent reviewers. The pooled prevalence of polypharmacy was estimated utilizing the random effects model using the default double arcsine transformation.Results: This review involved 14 studies comprising of 17 201 participants, a significant proportion of which were males (56.12%). The mean age of the review population was 61.96 (SD ± 11.51) years. The overall pooled prevalence of polypharmacy amongst patients with CKD was 69% (95% CI: 49%–86%) (I2 = 100%, p < 0.0001), with a proportionately higher prevalence in North America and Europe as compared to Asia.Conclusion: The results from this meta-analysis showed a high pooled prevalence estimates of polypharmacy amongst patient cohorts with CKD. The exact interventions that are likely to significantly mitigate its effect remain uncertain and will need exploration by future prospective and systematic studies.Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42022306572].

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Findings from these studies were encouraging as pharmacist-led services were mostly associated with favorable outcomes. [44][45][46][47] The beneficial influence of pharmacists has also been proven in emergent situation particularly the recent COVID-19 pandemic where pharmacists undertook additional clinical roles and initiated novel pandemic-driven services. 12,48 This proves that pharmacists are capable of expanding their pharmaceutical care activities in emergency situations and supports the efforts for embracing new roles for pharmacists.…”

Section: Implication For Practice and Researchmentioning

confidence: 99%

Disaster Preparedness Amongst Emergency Pharmacists for the FIFA World Cup Qatar 2022™: A Cross-Sectional Survey

Isleem¹,

Naseralallah²,

Koraysh³

et al. 2023

RMHP

Self Cite

View full text Add to dashboard Cite

The aim of this study is to assess the level of preparedness of pharmacists working in the emergency department at Hamad Medical Corporation (HMC) for any emergency disasters that may take place during the FIFA World Cup Qatar 2022™ by evaluating their awareness (A), attitude (A), and readiness (R). Methods: A cross-sectional quantitative observational study was conducted through a web-based survey. The survey was distributed among emergency pharmacists working in general hospitals under HMC. The questionnaire was composed of three major domains assessing awareness, attitude, readiness, as well as an additional domain to collect the participants' demographics. Student's t-test, analysis of variance, Pearson's correlation, and linear regression were used with an alpha level of 0.05. Results: Most pharmacists working in the emergency departments at HMC had high levels of awareness (76.9%), attitude (92%), and readiness (53.8%) for any emergency disasters that may occur during the FIFA World Cup 2022. Nonetheless, almost half of the respondents reported moderate level of readiness for emergency events. Pharmacists with >10 years' practice experience had significantly higher AAR score compared to those with <5 years' experience (P = 0.002). Significant direct positive correlations were found among the 3 AAR parameters (P < 0.05). Attitude was found to be a significant predictor of readiness (P < 0.05). A model composed of attitude and awareness could predict 12% of readiness score. Conclusion: Emergency pharmacists at HMC have high level of preparedness for any emergency disaster event during the World Cup. Future research should focus on the development of theory-based action framework for pharmacy departments during mass gathering events.

show abstract

“…Previous studies that evaluated the effectiveness of clinical pharmacy services in hospital settings have highlighted their demonstrable clinical,23–26 economical26–29 and humanistic30–34 benefits. However, despite evidence supporting their advantages, these services lack uniform integration across global healthcare systems 14 15.…”

Section: Introductionmentioning

confidence: 99%

Multifaceted pharmacist-led interventions in secondary care settings between countries of various income levels: a scoping review protocol

Tharmalinga Sharma,

McMillan,

Samaranayake

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionClinical pharmacy services often involve multifaceted pharmacist-led interventions. However, current pharmacy practice models vary across different countries. Despite the documented benefits of clinical pharmacy services, the characteristics of pharmacist-led interventions in different countries have not yet been adequately explored and described. Therefore, this protocol outlines the methodology for a proposed scoping review aiming to investigate various types of multifaceted pharmacist-led interventions and the outcomes used to evaluate their effectiveness within secondary care settings. Additionally, the scoping review will map the current evidence surrounding the characteristics of interventions and outcomes reported across various countries of socioeconomic status.Methods and analysisThe scoping review will be conducted according to the JBI Methodology for Scoping Reviews and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Extension for Scoping Reviews. We will systematically search the following electronic databases: MEDLINE (Ovid), CINAHL (EbscoHost), Embase (embase.com), Scopus (scopus.com), Cochrane Library (cochranelibrary.com) and APA PsycInfo (Ovid). Additionally, the reference lists of identified reviews and included full texts will be searched for relevant papers. Grey literature sources, such as International Pharmaceutical Abstracts and the International Pharmaceutical Federation (FIP) website, will be searched. We will include primary studies published in the English language from January 2013 to December 2023, involving secondary care multifaceted pharmacist-led interventions. Two independent reviewers will screen studies against eligibility criteria and use a piloted data extraction form to extract relevant information. We will extract relevant data, complete a tabular summary from each included publication and analyse it.Ethics and disseminationEthical approval is not required as we will be using data from publicly available literature sources. Findings will be disseminated in publications and presentations with relevant stakeholders. We aim to map available evidence across the breadth of studies that have reported multifaceted pharmacist-led interventions and their outcomes.

show abstract

A systematic review on the impact of pharmacist‐provided services on patients’ health outcomes in Arab countries

Cited by 11 publications

References 76 publications

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis

Disaster Preparedness Amongst Emergency Pharmacists for the FIFA World Cup Qatar 2022™: A Cross-Sectional Survey

Multifaceted pharmacist-led interventions in secondary care settings between countries of various income levels: a scoping review protocol

Contact Info

Product

Resources

About